Annexon to present at the j.p. morgan 39th annual healthcare conference

South san francisco, calif., jan. 05, 2021 (globe newswire) -- annexon, inc. (“annexon”) (nasdaq: annx), a clinical stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated autoimmune and neurodegenerative disorders of the body, brain and eye, today announced that a corporate update will be presented at the 39th annual j.p. morgan healthcare conference on january 12, 2021 at 4:30pm et.
ANNX Ratings Summary
ANNX Quant Ranking